Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma ; volume:6 ; number:6 ; day:22 ; month:9 ; year:2004 ; pages:1-7 ; date:12.2004
Breast cancer research ; 6, Heft 6 (22.9.2004), 1-7, 12.2004
- Creator
-
Kitayama, Joji
- Contributor
-
Shida, Dai
Sako, Akihiro
Ishikawa, Makoto
Hama, Kotaro
Aoki, Junken
Arai, Hiroyuki
Nagawa, Hirokazu
SpringerLink (Online service)
- DOI
-
10.1186/bcr935
- URN
-
urn:nbn:de:1111-2016032354697
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kitayama, Joji
- Shida, Dai
- Sako, Akihiro
- Ishikawa, Makoto
- Hama, Kotaro
- Aoki, Junken
- Arai, Hiroyuki
- Nagawa, Hirokazu
- SpringerLink (Online service)
Other Objects (12)
Over-expression of NOTCH1 as a biomarker for invasive breast ductal carcinoma
Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast
The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast
Overexpression of TPL2 may be a predictor of good prognosis in patients with breast invasive ductal carcinoma
Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ
Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma
Common genetic susceptibility to DCIS and invasive ductal carcinoma
Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ
Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis
Differentiation between invasive ductal carcinoma and ductal carcinoma in situ by combining intratumoral and peritumoral ultrasound radiomics
Clinicopathologic features of invasive metaplastic and micropapillary breast carcinoma: comparison with invasive ductal carcinoma of breast
The longitudinal risk of mortality between invasive ductal carcinoma and metaplastic breast carcinoma
Over-expression of NOTCH1 as a biomarker for invasive breast ductal carcinoma
Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast
The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast
Overexpression of TPL2 may be a predictor of good prognosis in patients with breast invasive ductal carcinoma
Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ
Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma
Common genetic susceptibility to DCIS and invasive ductal carcinoma
Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ
Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis
Differentiation between invasive ductal carcinoma and ductal carcinoma in situ by combining intratumoral and peritumoral ultrasound radiomics
Clinicopathologic features of invasive metaplastic and micropapillary breast carcinoma: comparison with invasive ductal carcinoma of breast
The longitudinal risk of mortality between invasive ductal carcinoma and metaplastic breast carcinoma
Over-expression of NOTCH1 as a biomarker for invasive breast ductal carcinoma
Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast
The clinicopathological significance of Mortalin overexpression in invasive ductal carcinoma of breast
Overexpression of TPL2 may be a predictor of good prognosis in patients with breast invasive ductal carcinoma
Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ
Comparison of clinical outcomes between luminal invasive ductal carcinoma and luminal invasive lobular carcinoma
Common genetic susceptibility to DCIS and invasive ductal carcinoma
Clinicopathological characteristics and prognosis of triple-negative breast cancer invasive ductal carcinoma with ductal carcinoma in situ
Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis
Differentiation between invasive ductal carcinoma and ductal carcinoma in situ by combining intratumoral and peritumoral ultrasound radiomics
Clinicopathologic features of invasive metaplastic and micropapillary breast carcinoma: comparison with invasive ductal carcinoma of breast